Shield’s First SBIR April 1, 2019 admin 1 Comment Shield Pharma LLC has been awarded a Phase I SBIR to develop its first compound. We hope to publish results next year.
Hi, this is a comment.To delete a comment, just log in and view the post's comments. There you will have the option to edit or delete them. Reply
Hi, this is a comment.
To delete a comment, just log in and view the post's comments. There you will have the option to edit or delete them.